2023 /PRNewswire/ -- Persephone Biosciences Inc., a synthetic biology company reimagining patient health through the microbiome, and Ginkgo Bioworks (NYSE: DNA), which is building the leading ...

Persephone Biosciences and Ginkgo Bioworks Complete Reusable Bacteroides Anaerobic Engineering Toolkit

Assembly Biosciences (NASDAQ:ASMB) stock is taking off on Tuesday after announcing a massive collaboration with Gilead Sciences (NASDAQ:GILD). According to a press release, these two companies ...

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today?

Shares of Assembly Biosciences more than doubled in premarket trading Tuesday after the biotechnology company inked a collaboration deal potentially worth hundreds of millions of dollars with ...

Assembly Biosciences Shares Soar Premarket on Gilead Pact

“Working with Revvity will allow us to greatly expand the reach of high-quality sequencing as part of a complete solution for the benefit of customers everywhere,” said Yaron Hakak, SVP of corporate and business development at Element Bioscience

Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow

JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, announced today completion of a D ...

Atom Bioscience Raises $83M in a D-Round Financing…

Analysts have provided the following ratings for Harmony Biosciences (NASDAQ:HRMY) within the last quarter: These 15 analysts have an average price target of $54.2 versus the current price of ...

Analyst Ratings for Harmony Biosciences

Piper Sandler analyst David Amsellem reiterated a Buy rating on Harmony Biosciences Holdings (HRMY – Research Report) today and set a price target of $42.00. The company’s shares closed last ...

Piper Sandler Sticks to Its Buy Rating for Harmony Biosciences Holdings (HRMY)

SAN DIEGO, CA / ACCESSWIRE / October 13, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage company applying transformative chemistry to improve prescription ...

Ensysce Biosciences, Inc.: Ensysce Biosciences Releases "Highlights Video" of PAINWeek 2023 Symposium

Lexaria now holds 37 granted patents world-wide Potential application in treating nicotine addiction KELOWNA, BC / ACCESSWIRE / October 12, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ ...

Lexaria Bioscience Corp.: Lexaria Granted Two New Patents in Canada

Get the most recent info and news about Sidero Bioscience on HackerNoon, where 10k+ technologists publish stories for 4M+ monthly readers.

Iron deficiency, anemia, anemia management, medical foods. 

SIDERO BIOSCIENCE

siderobio.com

1-10 employees

Since 2007

COMPANY RANKING

SIDERO BIOSCIENCE

EVERGREEN INDEX #9725

Representing this company? Click here to claim and customize this page!

Sidero Bioscience WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

SIDERO BIOSCIENCE

siderobio.com

1-10 employees

Since 2007

COMPANY RANKING

SIDERO BIOSCIENCE

EVERGREEN INDEX #9725

RELATED COMPANIESRANK

STORIES ABOUT SIDERO BIOSCIENCE

Representing this company? Click here to claim and customize this page!

Sidero Bioscience WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!